Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Cash & Equivalents (2016 - 2025)

Myomo filings provide 10 years of Cash & Equivalents readings, the most recent being $12.6 million for Q3 2025.

  • On a quarterly basis, Cash & Equivalents rose 79.4% to $12.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $12.6 million, a 79.4% increase, with the full-year FY2024 number at $24.4 million, up 254.7% from a year prior.
  • Cash & Equivalents hit $12.6 million in Q3 2025 for Myomo, down from $14.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $24.4 million in Q4 2024 to a low of $5.3 million in Q4 2022.
  • Median Cash & Equivalents over the past 5 years was $10.2 million (2022), compared with a mean of $11.4 million.
  • Biggest five-year swings in Cash & Equivalents: crashed 65.56% in 2022 and later surged 271.11% in 2025.
  • Myomo's Cash & Equivalents stood at $15.5 million in 2021, then crashed by 65.56% to $5.3 million in 2022, then increased by 28.53% to $6.9 million in 2023, then surged by 254.7% to $24.4 million in 2024, then plummeted by 48.49% to $12.6 million in 2025.
  • The last three reported values for Cash & Equivalents were $12.6 million (Q3 2025), $14.6 million (Q2 2025), and $20.2 million (Q1 2025) per Business Quant data.